ARF6 inhibitor for treatment of acute lung injury/acute respiratory distress syndrome

Ended Project Grant Awarded Last action

Award ID
W81XWH2010239
Recipient
Awarding agency
Obligated
$3,266,291

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Originally
Place of performance
Emigration Canyon, UT 84108, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment Extends the POP by 12 months ARF6 inhibitor for treatment of acute lung injury/acute respiratory distress syndrome $0
Amendment $0
Amendment $0
Original award $3,266,291

Quick answers

Who received award W81XWH2010239?

W81XWH2010239 was awarded to Navigen Inc. by Defense Health Agency (Department of Defense) on June 1, 2020.

How much is award W81XWH2010239 worth?

$3,266,291 has been obligated on W81XWH2010239.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award